Dianthus Therapeutics (DNTH) Shares Outstanding (2017 - 2025)
Historic Shares Outstanding for Dianthus Therapeutics (DNTH) over the last 8 years, with Q3 2025 value amounting to $42.9 million.
- Dianthus Therapeutics' Shares Outstanding rose 4593.08% to $42.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.9 million, marking a year-over-year increase of 4593.08%. This contributed to the annual value of $31.1 million for FY2024, which is 10998.77% up from last year.
- Dianthus Therapeutics' Shares Outstanding amounted to $42.9 million in Q3 2025, which was up 4593.08% from $32.2 million recorded in Q2 2025.
- Over the past 5 years, Dianthus Therapeutics' Shares Outstanding peaked at $42.9 million during Q3 2025, and registered a low of $10.3 million during Q1 2022.
- Moreover, its 4-year median value for Shares Outstanding was $32.1 million (2025), whereas its average is $28.9 million.
- The largest annual percentage gain for Dianthus Therapeutics' Shares Outstanding in the last 5 years was 22273.62% (2023), contrasted with its biggest fall of 5555.08% (2023).
- Dianthus Therapeutics' Shares Outstanding (Quarter) stood at $33.3 million in 2022, then crashed by 55.55% to $14.8 million in 2023, then skyrocketed by 109.99% to $31.1 million in 2024, then surged by 37.73% to $42.9 million in 2025.
- Its Shares Outstanding was $42.9 million in Q3 2025, compared to $32.2 million in Q2 2025 and $32.1 million in Q1 2025.